Back to User profile » Dr Laura Periman
Papers published by Dr Laura Periman:
Effect of Cyclosporine Ophthalmic Solution 0.09% on Signs and Symptoms of Dry Eye Disease in Patients Inadequately Controlled on Cyclosporine Ophthalmic Emulsion 0.05%: Results from a Single-Arm, Open-Label, Phase 4 Study
Johnston J, Adler R, Hessen M, Nichols KK, White D, Saenz B, Bowden F III, Periman LM, Truett K, Urbieta M, Mitchell B
Clinical Ophthalmology 2026, 20:583071
Published Date: 4 March 2026
The Demodex Expert Panel on Treatment and Eyelid Health (DEPTH) Consensus Regarding the Preferred Treatment for Demodex Blepharitis
Donnenfeld E, Nichols KK, Ayres BD, Farid M, Gupta PK, Lindstrom RL, Pflugfelder S, Starr CE, Venkateswaran N, Gaddie IB, Karpecki PM, Koetting C, McGee S, Periman LM, Yeu E
Clinical Ophthalmology 2025, 19:1893-1904
Published Date: 18 June 2025
Personalized Management of Dry Eye Disease: Beyond Artificial Tears
Matossian C, Crowley M, Periman L, Sorkin S
Clinical Ophthalmology 2022, 16:3911-3918
Published Date: 24 November 2022
A Review of the Mechanism of Action of Cyclosporine A: The Role of Cyclosporine A in Dry Eye Disease and Recent Formulation Developments
Periman LM, Mah FS, Karpecki PM
Clinical Ophthalmology 2020, 14:4187-4200
Published Date: 2 December 2020
Improving Tolerance and Compliance with Topical Immunomodulators Using Micro-Emulsion Lipid Layer Artificial Tears
Epitropoulos AT, Therattil A, Periman LM, Rosenberg ED
Clinical Ophthalmology 2020, 14:1921-1929
Published Date: 6 July 2020